Summary of blog post from FDA, by Troy Tazbaz:
The FDA emphasizes the importance of integrating AI responsibly, ensuring safety and effectiveness through collaboration and adherence to standards and best practices. Key strategies include adopting risk management frameworks, quality assurance practices, and maintaining transparency and accountability throughout the AI development lifecycle. Grassroots efforts and federal initiatives are contributing to the establishment of best practices for AI quality assurance in health care. The FDA’s Digital Health Center of Excellence (DHCoE) remains open to feedback and collaboration to advance AI in health care.